EchoPixel is a company that develops technology designed to transform patient care. They have created 3D holographic technology that facilitates and personalizes heart procedures for patients called True3D. In 2015, they were approved by the US Food and Drug Administration (FDA) to introduce a new generation of medical visualization solutions that will transform the practice and study of healthcare.
True3D has already been tested in various facilities around North America, including Sick Kids Hospital in Toronto, Canada; Cincinnati Children’s Hospital Medical Center in Cincinnati, Ohio; and Cook Children’s Hospital in Fort Worth, Texas. This medical visualization is known as a “mixed reality” software. It is a touchless, interactive, 3D anatomical imaging tool which will allow cardiologists and surgeons plan and carry out their heart procedures in the operating room.
The system uses scans and other data from CT, MR, echocardiography and C-arm fluoroscopy to create life-size holographic versions of organs, blood vessels and other structures that allow doctors to interact with it just like they would with a real-life organ. The ability to interact with a holographic organ gives doctors the capacity to identify the most optimal procedure by receiving precise measurements, angles and distances.
“EchoPixel’s technology lets you effortlessly interact with 3D images to better understand complex cardiac anatomy and the anatomic variability that is commonly seen in structural heart disease patients,” said Dr. Saurabh Sanon, director of the Structural Heart Transcatheter Therapies program at Palm Beach Gardens Medical Center and clinical associate professor of medicine at Florida Atlantic University’s College of Medicine, in a press release.
According to the latest research, the global medical holography market is expected to reach $14.25B by 2023. @EchoPixel_Inc is named among key market players. #RunaFamily
Learn more → https://t.co/ng7GIhWLM6 pic.twitter.com/2xoUF2hDN0
— Runa Capital (@RunaCapital) July 18, 2018
They are currently comparing the procedure times for those using the technology and not using it, to see if times are cut down. So far, they are witnessing promising results and if these results continue, then they think the technology will make structural heart procedures more efficient and accessible to patients.
In August, a team of researchers from Carnegie Mellon University used 3-D printing technology to create different components of the heart. They called it Freeform Reversible Embedding of Suspended Hydrogels (FRESH). Here, the goal was to try and offer patients another chance at life by giving them a new heart.
The research towards trying to find treatments to various types of heart diseases are limitless. But, EchoPixel is the first of its kind to debut a 3D holographic technology that offers real-time interactive mixed reality intraoperative anatomical imaging and planning capabilities.
EchoPixel plans to eventually integrate its True3D software with artificial intelligence and robotics to “enable the completion of more precise and personalized procedures,” according to the CEO of EchoPixel, Sergio Aguirre.